Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Lancet HIV. 2021 Sep 9;8(10):e614–e622. doi: 10.1016/S2352-3018(21)00158-2

Figure 1: Hazard ratios (solid lines) with 95% confidence intervals (shaded areas) for cancer incidence, comparing a grid of baseline CD4 cell counts to the reference value of 200 cells/μL.

Figure 1:

The models for any cancer, Kaposi sarcoma, non-Hodgkin lymphoma and Hodgkin lymphoma are adjusted for age, sex, and baseline calendar period. The model for cervical cancer is adjusted for age and baseline calendar period. The model for leukaemia is not adjusted for other variables.